Dyspnea Self-Management: Internet or Face-to-Face

Completed · Phase 1/Phase 2

Conditions studied: Chronic Obstructive Pulmonary Disease (COPD)

In brief

Chronic obstructive pulmonary disease, including emphysema and chronic bronchitis, is the fourth most common cause of death and the second leading cause of disability in the United States. COPD is estimated to be responsible for more than 13.4 million physician visits and 13% of hospitalizations nationally. These hospitalizations are usually caused by acute exacerbations characterized by an increase in symptoms including dyspnea or shortness of breath (SOB), cough, wheezing, and sputum production. The significant disability for people with COPD is primarily due to the symptom of dyspnea (shortness of breath) that affects an individual's quality of life more than does the physiological impairment. Despite optimal medical and pharmacological therapy, most people with COPD continue to suffer from chronic and progressive dyspnea and other symptoms of cough and fatigue. We have previously shown that an individualized face-to-face dyspnea self-management program was effective in improving dyspnea with activities of daily living (ADL), physical functioning, and self-efficacy for managing dyspnea. Using an experimental longitudinal design, the i-DSMP will be compared to the Face-to-Face Dyspnea Self-Management Program (f-DSMP) and to an Attention Control (AC) intervention

Key facts

Study ID

NCT00461162

Run by

University of California, San Francisco

People needed

125

Starts

2007-01-01

Expected to finish

2011-08-01

Last updated by the study team

2014-08-18

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants will have:
• a diagnosis of COPD which is clinically stable (including medications) for at least one month;
• spirometry results showing at least mild obstructive disease defined as post bronchodilator forced expiratory volume in one second (FEV1)/forced vital capacity (FVC) ratio <0.70 with FEV1<80% predicted or post-bronchodilator FEV1/FVC ratio <0.60 with FEV1>80% predicted;
• ADL limited by dyspnea;
• a designated primary care physician;
• ability to speak English and sign consent form;
• actively using a computer and the Internet;
• no formal pulmonary rehabilitation training for at least 12 months;
• patients receiving supplemental oxygen will be acceptable if their O2 saturation can be maintained at >80% on <6L/min of nasal oxygen;
• understands how to and is able to rate their shortness of breath during exercise;
• age > 40 years.

You may not qualify if…

• Subjects will be excluded if they have active symptomatic illness (e.g., cancer, left heart failure, ischemic heart disease with known coronary artery or valvular heart disease, psychiatric illness, and neuromuscular disease).

Where it is running

• Dyspnea Research Group, Dept. of Physiological Nursing, University of California, San Francisco — San Francisco, California, United States
• University of Washington, Seattle - Dept. of Biobehavioral Nursing and Health Systems — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.